142 related articles for article (PubMed ID: 37763744)
21. Immunotherapy-Based Neoadjuvant Treatment of Advanced Microsatellite Instability-High Gastric Cancer: A Case Series.
Liu L; Woo Y; D'Apuzzo M; Melstrom L; Raoof M; Liang Y; Afkhami M; Hamilton SR; Chao J
J Natl Compr Canc Netw; 2022 Aug; 20(8):857-865. PubMed ID: 35948034
[TBL] [Abstract][Full Text] [Related]
22. Mismatch Repair Status of Gastric Cancer and Its Association with the Local and Systemic Immune Response.
Shin SJ; Kim SY; Choi YY; Son T; Cheong JH; Hyung WJ; Noh SH; Park CG; Kim HI
Oncologist; 2019 Sep; 24(9):e835-e844. PubMed ID: 30894409
[TBL] [Abstract][Full Text] [Related]
23. Allelic imbalance at p53 and microsatellite instability are predictive markers for resistance to chemotherapy in gastric carcinoma.
Yashiro M; Inoue T; Nishioka N; Matsuoka T; Boland CR; Hirakawa K
Ann Surg Oncol; 2009 Oct; 16(10):2926-35. PubMed ID: 19597886
[TBL] [Abstract][Full Text] [Related]
24. A greater lymph node yield is required during pathological examination in microsatellite instability-high gastric cancer.
Cai Z; Song H; Fingerhut A; Sun J; Ma J; Zhang L; Li S; Yu C; Zheng M; Zang L
BMC Cancer; 2021 Mar; 21(1):319. PubMed ID: 33765970
[TBL] [Abstract][Full Text] [Related]
25. Prognostic Impact of Microsatellite Instability in Asian Gastric Cancer Patients Enrolled in the ARTIST Trial.
Miceli R; An J; Di Bartolomeo M; Morano F; Kim ST; Park SH; Choi MG; Lee JH; Raimondi A; Fucà G; Sohn TS; Bae JM; Kim S; Lim DH; Kang WK; Kim KM; Pietrantonio F; Lee J
Oncology; 2019; 97(1):38-43. PubMed ID: 31048579
[TBL] [Abstract][Full Text] [Related]
26. Microsatellite instability in sporadic gastric cancer: its prognostic role and guidance for 5-FU based chemotherapy after R0 resection.
An JY; Kim H; Cheong JH; Hyung WJ; Kim H; Noh SH
Int J Cancer; 2012 Jul; 131(2):505-11. PubMed ID: 21898388
[TBL] [Abstract][Full Text] [Related]
27. Correlation between microsatellite instability-high phenotype and occult lymph node metastasis in gastric carcinoma.
Choi J; Nam SK; Park DJ; Kim HW; Kim HH; Kim WH; Lee HS
APMIS; 2015 Mar; 123(3):215-22. PubMed ID: 25556520
[TBL] [Abstract][Full Text] [Related]
28. Predictive role of microsatellite instability for PD-1 blockade in patients with advanced gastric cancer: a meta-analysis of randomized clinical trials.
Pietrantonio F; Randon G; Di Bartolomeo M; Luciani A; Chao J; Smyth EC; Petrelli F
ESMO Open; 2021 Feb; 6(1):100036. PubMed ID: 33460964
[TBL] [Abstract][Full Text] [Related]
29. Microsatellite Instability Analysis in Gastric Carcinomas of Moroccan Patients.
Nshizirungu JP; Bennis S; Mellouki I; Benajah DA; Lahmidani N; El Bouhaddoutti H; Ibn Majdoub K; Ibrahimi SA; Pires Celeiro S; Viana-Pereira M; Manuel Reis R
Genet Test Mol Biomarkers; 2021 Feb; 25(2):116-123. PubMed ID: 33596142
[No Abstract] [Full Text] [Related]
30. Efficacy and safety of neoadjuvant immunotherapy in patients with microsatellite instability-high gastrointestinal malignancies: A case series.
Zhang Z; Cheng S; Gong J; Lu M; Zhou J; Zhang X; Li J; Shen L; Peng Z
Eur J Surg Oncol; 2020 Oct; 46(10 Pt B):e33-e39. PubMed ID: 32732092
[TBL] [Abstract][Full Text] [Related]
31. Elevated microsatellite instability at selected tetranucleotide (EMAST) repeats in gastric cancer: a distinct microsatellite instability type with potential clinical impact?
Herz AL; Wisser S; Kohlruss M; Slotta-Huspenina J; Jesinghaus M; Grosser B; Steiger K; Novotny A; Hapfelmeier A; Schmidt T; Gaida MM; Weichert W; Keller G
J Pathol Clin Res; 2022 May; 8(3):233-244. PubMed ID: 35099128
[TBL] [Abstract][Full Text] [Related]
32. [Chemoresistance in Microsatellite Instability-High Gastric Cancer-A Case Report].
Otani T; Ichikawa H; Hanyu T; Ishikawa T; Sakai T; Nemoto M; Muneoka Y; Usui K; Sudo N; Kano Y; Nagahashi M; Sakata J; Kobayashi T; Kameyama H; Wakai T
Gan To Kagaku Ryoho; 2018 Dec; 45(13):1895-1897. PubMed ID: 30692390
[TBL] [Abstract][Full Text] [Related]
33. Pattern of recurrence and overall survival in esophagogastric cancer after perioperative FLOT and clinical outcomes in MSI-H population: the PROSECCO Study.
Nappo F; Fornaro L; Pompella L; Catanese S; Lavacchi D; Spallanzani A; Cappetta A; Puzzoni M; Murgioni S; Barsotti G; Tirino G; Pellino A; Vivaldi C; Strippoli A; Aprile G; Di Donato S; Mazza E; Prisciandaro M; Antonuzzo L; Zagonel V; Cascinu S; De Vita F; Lonardi S
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6601-6611. PubMed ID: 36795195
[TBL] [Abstract][Full Text] [Related]
34. Survival impact of microsatellite instability in stage II gastric cancer patients who received S-1 adjuvant monotherapy after curative resection.
Sato C; Kawakami H; Tanaka R; Satake H; Inoue K; Kimura Y; Fujita J; Kawabata R; Chiba Y; Satoh T; Nakagawa K
Sci Rep; 2023 Jul; 13(1):10826. PubMed ID: 37402831
[TBL] [Abstract][Full Text] [Related]
35. Tumor mutation burden is correlated with response and prognosis in microsatellite-stable (MSS) gastric cancer patients undergoing neoadjuvant chemotherapy.
Li Z; Jia Y; Zhu H; Xing X; Pang F; Shan F; Li S; Wang D; Zhao F; Ma T; Wang S; Ji J
Gastric Cancer; 2021 Nov; 24(6):1342-1354. PubMed ID: 34406546
[TBL] [Abstract][Full Text] [Related]
36. Chemosensitivity and survival in gastric cancer patients with microsatellite instability.
Oki E; Kakeji Y; Zhao Y; Yoshida R; Ando K; Masuda T; Ohgaki K; Morita M; Maehara Y
Ann Surg Oncol; 2009 Sep; 16(9):2510-5. PubMed ID: 19565284
[TBL] [Abstract][Full Text] [Related]
37. KRAS Mutation in Gastric Cancer and Prognostication Associated with Microsatellite Instability Status.
Polom K; Das K; Marrelli D; Roviello G; Pascale V; Voglino C; Rho H; Tan P; Roviello F
Pathol Oncol Res; 2019 Jan; 25(1):333-340. PubMed ID: 29116623
[TBL] [Abstract][Full Text] [Related]
38. Expression Profile of Markers for Targeted Therapy in Gastric Cancer Patients: HER-2, Microsatellite Instability and PD-L1.
Pereira MA; Ramos MFKP; Dias AR; Faraj SF; Ribeiro RRE; de Castria TB; Zilberstein B; Alves VAF; Ribeiro U; de Mello ES
Mol Diagn Ther; 2019 Dec; 23(6):761-771. PubMed ID: 31595457
[TBL] [Abstract][Full Text] [Related]
39. A gene expression assay for simultaneous measurement of microsatellite instability and anti-tumor immune activity.
Danaher P; Warren S; Ong S; Elliott N; Cesano A; Ferree S
J Immunother Cancer; 2019 Jan; 7(1):15. PubMed ID: 30665466
[TBL] [Abstract][Full Text] [Related]
40. Adjuvant Chemotherapy for Gastric Cancer Patients with Mismatch Repair Deficiency or Microsatellite Instability: Systematic Review and Meta-Analysis.
Nie RC; Chen GM; Yuan SQ; Kim JW; Zhou J; Nie M; Feng CY; Chen YB; Chen S; Zhou ZW; Wang Y; Li YF
Ann Surg Oncol; 2022 Apr; 29(4):2324-2331. PubMed ID: 34796431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
